These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23851115)

  • 21. Synthesis, in vitro evaluation, and SAR studies of a potential antichagasic 1H-pyrazolo[3,4-b]pyridine series.
    Dias LR; Santos MB; Albuquerque Sd; Castro HC; de Souza AM; Freitas AC; DiVaio MA; Cabral LM; Rodrigues CR
    Bioorg Med Chem; 2007 Jan; 15(1):211-9. PubMed ID: 17064907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agents.
    Ferreira RS; Dessoy MA; Pauli I; Souza ML; Krogh R; Sales AI; Oliva G; Dias LC; Andricopulo AD
    J Med Chem; 2014 Mar; 57(6):2380-92. PubMed ID: 24533839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platinum-based complexes of bioactive 3-(5-nitrofuryl)acroleine thiosemicarbazones showing anti-Trypanosoma cruzi activity.
    Vieites M; Otero L; Santos D; Olea-Azar C; Norambuena E; Aguirre G; Cerecetto H; González M; Kemmerling U; Morello A; Diego Maya J; Gambino D
    J Inorg Biochem; 2009 Mar; 103(3):411-8. PubMed ID: 19187969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity on Trypanosoma cruzi, erythrocytes lysis and biologically relevant physicochemical properties of Pd(II) and Pt(II) complexes of thiosemicarbazones derived from 1-indanones.
    Santos D; Parajón-Costa B; Rossi M; Caruso F; Benítez D; Varela J; Cerecetto H; González M; Gómez N; Caputto ME; Moglioni AG; Moltrasio GY; Finkielsztein LM; Gambino D
    J Inorg Biochem; 2012 Dec; 117():270-6. PubMed ID: 23063173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain.
    Du X; Guo C; Hansell E; Doyle PS; Caffrey CR; Holler TP; McKerrow JH; Cohen FE
    J Med Chem; 2002 Jun; 45(13):2695-707. PubMed ID: 12061873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets.
    Otero L; Vieites M; Boiani L; Denicola A; Rigol C; Opazo L; Olea-Azar C; Maya JD; Morello A; Krauth-Siegel RL; Piro OE; Castellano E; González M; Gambino D; Cerecetto H
    J Med Chem; 2006 Jun; 49(11):3322-31. PubMed ID: 16722651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4-nitroacetophenone-derived thiosemicarbazones and their copper(II) complexes with significant in vitro anti-trypanosomal activity.
    Pérez-Rebolledo A; Teixeira LR; Batista AA; Mangrich AS; Aguirre G; Cerecetto H; González M; Hernández P; Ferreira AM; Speziali NL; Beraldo H
    Eur J Med Chem; 2008 May; 43(5):939-48. PubMed ID: 17709156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of the antiparasitic activity of bis-(arylmethylidene) cycloalkanones.
    Braga SF; Alves ÉV; Ferreira RS; Fradico JR; Lage PS; Duarte MC; Ribeiro TG; Júnior PA; Romanha AJ; Tonini ML; Steindel M; Coelho EF; de Oliveira RB
    Eur J Med Chem; 2014 Jan; 71():282-9. PubMed ID: 24321832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thiosemicarbazones derived from 1-indanones as new anti-Trypanosoma cruzi agents.
    Caputto ME; Fabian LE; Benítez D; Merlino A; Ríos N; Cerecetto H; Moltrasio GY; Moglioni AG; González M; Finkielsztein LM
    Bioorg Med Chem; 2011 Nov; 19(22):6818-26. PubMed ID: 22000947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of anti-Trypanosoma cruzi oxadiazoles leads to identification of compounds with efficacy in infected mice.
    dos Santos Filho JM; Moreira DR; de Simone CA; Ferreira RS; McKerrow JH; Meira CS; Guimarães ET; Soares MB
    Bioorg Med Chem; 2012 Nov; 20(21):6423-33. PubMed ID: 23006639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
    Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
    Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and mechanism of action studies.
    Rodríguez J; Arán VJ; Boiani L; Olea-Azar C; Lavaggi ML; González M; Cerecetto H; Maya JD; Carrasco-Pozo C; Cosoy HS
    Bioorg Med Chem; 2009 Dec; 17(24):8186-96. PubMed ID: 19900812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diaminomaleonitrile derivatives as new potential antichagasic compounds: a study of structure-activity relationships.
    de Oliveira AS; S Mello LD; H Ogihara C; H Döring T; L Palomino-Salcedo D; Michelan-Duarte S; Lg Ferreira L; M Souza J; Dávila-Rodríguez MJ; Cruz Júnior JWD; R Dockal E; D Andricopulo A
    Future Med Chem; 2021 Dec; 13(24):2167-2183. PubMed ID: 34708659
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies.
    Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD
    J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain.
    Fujii N; Mallari JP; Hansell EJ; Mackey Z; Doyle P; Zhou YM; Gut J; Rosenthal PJ; McKerrow JH; Guy RK
    Bioorg Med Chem Lett; 2005 Jan; 15(1):121-3. PubMed ID: 15582423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design.
    Aguirre G; Cabrera E; Cerecetto H; Di Maio R; González M; Seoane G; Duffaut A; Denicola A; Gil MJ; Martínez-Merino V
    Eur J Med Chem; 2004 May; 39(5):421-31. PubMed ID: 15110968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular features for antitrypanosomal activity of thiosemicarbazones revealed by OPS-PLS QSAR studies.
    Lozano NB; Maltarollo VG; Weber KC; Honorio KM; Guido RV; Andricopulo AD; Da Silva AB
    Med Chem; 2012 Nov; 8(6):1045-56. PubMed ID: 22779790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
    Bollini M; Casal JJ; Alvarez DE; Boiani L; González M; Cerecetto H; Bruno AM
    Bioorg Med Chem; 2009 Feb; 17(4):1437-44. PubMed ID: 19168363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, Cruzain docking, and in vitro studies of aryl-4-oxothiazolylhydrazones against Trypanosoma cruzi.
    Leite AC; Moreira DR; Cardoso MV; Hernandes MZ; Alves Pereira VR; Silva RO; Kiperstok AC; Lima Mda S; Soares MB
    ChemMedChem; 2007 Sep; 2(9):1339-45. PubMed ID: 17628867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ruthenium complexation on trypanocidal activity of 5-nitrofuryl containing thiosemicarbazones.
    Pagano M; Demoro B; Toloza J; Boiani L; González M; Cerecetto H; Olea-Azar C; Norambuena E; Gambino D; Otero L
    Eur J Med Chem; 2009 Dec; 44(12):4937-43. PubMed ID: 19783078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.